Notably, Fli1 silencing in human dermal MVECs was demonstrated to enhance both gene and protein expression of this adipokine, further suggesting that Fli1 deficiency may influence EC phenotype in SSc [27]. This evidence concerns the gene FLI1 and systemic sclerosis.